Gemzar and malignant neoplasm progression Patient Reports February 13, 2012

Gemzar Side Effects Report #4822125-9
Gemzar side effect was reported by a Physician from GERMANY on Oct 17, 2005. Female patient, 53 years of age, weighting 152.1 lb, was diagnosed with urethral cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, benign intracranial hypertension, cerebrovascular accident, eye haemorrhage, hemianopia, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN, MORPHINE, DURAGESIC, EPOGEN. Patient recovered.

Gemzar Side Effects Report #5212043-9
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2007. Male patient, 63 years of age, was diagnosed with urethral cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoptysis, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, PROCRIT. Patient recovered.

Gemzar Side Effects Report #5215581-8
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 15, 2007. Male patient, 63 years of age, was diagnosed with urethral cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoptysis, malignant neoplasm of renal pelvis, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #6114679-X
Gemzar side effect was reported by a Health Professional from UNITED STATES on Feb 15, 2008. Female patient, 56 years of age, was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Gemzar dosage: 1600 MG OTHER UNK. During the same period patient was treated with CISPLATIN, ATIVAN. Patient recovered.

Gemzar Side Effects Report #4853709-X
Gemzar side effect was reported by a Physician from GERMANY on Dec 01, 2005. Female patient, 53 years of age, weighting 152.1 lb, was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, atrial septal defect, benign intracranial hypertension, eye haemorrhage, hemianopia, malignant neoplasm progression, pancytopenia, papilloedema. Gemzar dosage: 1000 MG/M2, INTRAVENOUS; INTRAVENOUS. During the same period patient was treated with CARBOPLATINE TEVA, MORPHINE, DURAGESIC, ERYTHROPOIETIN. Patient recovered.

Gemzar Side Effects Report #4614132-6
Gemzar side effect was reported by a Physician from on Mar 02, 2005. Female patient, 71 years of age, was diagnosed with sarcoma uterus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activities of daily living impaired, cyst, disease progression, disease recurrence, malignant neoplasm progression, metastases to bone, metastases to central nervous system, metastases to lymph nodes. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, GRANISETRON, METOCLOPRAMIDE, HS BLOCKER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5130119-1
Gemzar side effect was reported by a Health Professional from JAPAN on Sept 29, 2006. Male patient, 53 years of age, was diagnosed with prostate cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone lesion, malignant neoplasm progression, neutropenia, thrombocytopenia. Gemzar dosage: 1000 MG/M2, INTRAVENOUS ; INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN. Patient died on 07/01/2003.

Gemzar Side Effects Report #4954921-1
Gemzar side effect was reported by a Physician from JAPAN on Mar 08, 2006. Male patient, 73 years of age, weighting 97.00 lb, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, lymphangiosis carcinomatosa, malignant neoplasm progression, pneumonia chlamydial, pneumonitis. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, NASEA, DEXAMETHASONE PHOSPHATE, LASIX, NAUZELIN, MAGLAX, ALUMINIUM HYDROXIDE W. Patient was hospitalized. Patient died on 02/05/2006.

Gemzar Side Effects Report #5759604-6
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Male patient, 63 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atrioventricular block, interstitial lung disease, malignant neoplasm progression, neutropenia, pneumocystis jiroveci pneumonia, pneumonia cytomegaloviral, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with VINORELBINE. Patient died.

Gemzar Side Effects Report #5836630-X
Gemzar side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, weighting 103.8 lb, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, lymphangiosis carcinomatosa, malignant neoplasm progression, pericarditis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, HUMALOG, ADALAT, OMEPRAZOLE, NITROL, MAGMITT, LOXONIN, SELBEX. Patient died on 06/13/2008.

Gemzar Side Effects Report #5106174-1
Gemzar side effect was reported by a Physician from JAPAN on Aug 23, 2006. Female patient, 79 years of age, was diagnosed with peritoneal mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: intestinal obstruction, malignant neoplasm progression, peritoneal mesothelioma malignant, pleural effusion. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient died.

Gemzar Side Effects Report #4824558-3
Gemzar side effect was reported by a Physician from GERMANY on Oct 24, 2005. Male patient, 64 years of age, weighting 198.4 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, catheter related complication, intervertebral disc protrusion, leukopenia, malignant neoplasm progression, peritoneal mesothelioma malignant, pneumonitis, staphylococcal infection

. Gemzar dosage: unknown. During the same period patient was treated with ALLOPURINOL, ATACAND HCT. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642562-5
Gemzar side effect was reported by a Physician from on Apr 01, 2005. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, biliary tract infection, condition aggravated, decreased appetite, malignant neoplasm progression, pancreatic carcinoma stage iv, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LOXONIN, SELBEX, LENDORM, URSODIOL, PURSENNID. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5566686-3
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice

, jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4855684-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 29, 2005. Male patient, 74 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, cholangitis acute, condition aggravated, disseminated intravascular coagulation, jaundice

, malignant neoplasm progression, pancreatic carcinoma, pleural effusion. Gemzar dosage: unknown. During the same period patient was treated with OMEPRAL, PRIMPERAN, AMLODIN, MAGLAX, LAXOBERON, GASMOTIN. Patient was hospitalized. Patient died on 08/08/2004.

Gemzar Side Effects Report #4871137-8
Gemzar side effect was reported by a Health Professional from JAPAN on Dec 15, 2005. Male patient, 74 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, cholangitis acute, disseminated intravascular coagulation, malignant neoplasm progression, pancreatic carcinoma, pleural effusion, pneumonitis, renal failure. Gemzar dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PRIMPERAN, AMLODIPINE BESYLATE, MAGLAX, LAXOBERON, GASMOTIN. Patient was hospitalized. Patient died on 08/08/2004.

Gemzar Side Effects Report #5072551-0
Gemzar side effect was reported by a Physician from JAPAN on July 19, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonitis. Gemzar dosage: 500 MG/BODY, INTRAVENOUS. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 01/01/2005.

Gemzar Side Effects Report #4655896-5
Gemzar side effect was reported by a Physician from on Apr 15, 2005. Male patient, 72 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, back pain

, blood lactate dehydrogenase increased, cardiomyopathy

, haematuria, malignant neoplasm progression, pancreatic carcinoma, white blood cells urine positive. Gemzar dosage: 1600 MG OTHER. During the same period patient was treated with LOPRESSOR, LENDORM, CHINESE MEDICINE, VOLTAREN, NAIXAN, MUCOSTA, BERIZYM, RIBALL. Patient recovered.

Gemzar Side Effects Report #4883916-1
Gemzar side effect was reported by a Health Professional from JAPAN on Jan 04, 2006. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal infection, ileus paralytic, malignant ascites, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient died on 09/16/2002.

Gemzar Side Effects Report #5054551-X
Gemzar side effect was reported by a Physician from JAPAN on June 28, 2006. Male patient, 69 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary dilatation, cholangitis, malignant neoplasm progression, pancreatic carcinoma, pneumonitis. Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. During the same period patient was treated with LOXONIN, MUCOSTA, SULPERAZON, FUTHAN, FAMOTIDINE. Patient died on 06/14/2006.

Gemzar Side Effects Report #5071769-0
Gemzar side effect was reported by a Physician from JAPAN on July 20, 2006. Male patient, 69 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis, dilatation intrahepatic duct acquired, malignant neoplasm progression, pancreatic carcinoma, pneumonitis. Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. During the same period patient was treated with LOXONIN, MUCOSTA, SULPERAZON, FUTHAN, FAMOTIDINE. Patient died on 06/14/2006.

Gemzar Side Effects Report #5318947-0
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 68 years of age, weighting 103.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, gastrointestinal haemorrhage, haemoglobin decreased, malignant neoplasm progression, nephritis interstitial, renal failure acute. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with GASTER, LOXONIN, SELBEX, LASIX. Patient died on 12/13/2002.

Gemzar Side Effects Report #5740446-2
Gemzar side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hepatic failure, jaundice

, liver disorder, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 04/01/2008.

Gemzar Side Effects Report #4710768-2
Gemzar side effect was reported by a Physician from JAPAN on June 25, 2005. Female patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain

, cerebral artery stenosis, cerebral infarction, dysarthria, hemiplegia, malignant neoplasm progression, myocardial infarction, pancreatic carcinoma stage iv, peritonitis. Gemzar dosage: 1400 MG OTHER. Patient was hospitalized and became disabled. Patient died on 02/04/2005.

Gemzar Side Effects Report #5392247-5
Gemzar side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastric perforation, gastric ulcer, malignant neoplasm progression, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 09/13/2006.

Gemzar Side Effects Report #4551258-X
Gemzar side effect was reported by a Health Professional from on Dec 21, 2004. Male patient, 64 years of age, weighting 147.7 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, haematoma, haemoglobin decreased, jaundice cholestatic, malignant neoplasm progression, pyrexia, venous thrombosis limb. Gemzar dosage: 1000MG/M2 OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4600326-2
Gemzar side effect was reported by a Physician from on Feb 10, 2005. Female patient, 63 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain

, cerebral artery stenosis, cerebral infarction, dysarthria, dyspnoea, echocardiogram abnormal, electrocardiogram abnormal, malignant neoplasm progression, myocardial infarction. Gemzar dosage: 1400 MG OTHER. Patient was hospitalized and became disabled. Patient recovered.

Gemzar Side Effects Report #4692373-X
Gemzar side effect was reported by a Health Professional from on June 01, 2005. Female patient, 61 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph increased, interstitial lung disease, lung infiltration, malignant neoplasm progression, white blood cell count decreased. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with MS CONTIN, LOXONIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5053594-X
Gemzar side effect was reported by a Physician from JAPAN on June 23, 2006. Female patient, 58 years of age, weighting 130.1 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebellar infarction, cerebral infarction, cerebral ischaemia, dehydration, haematemesis, heart rate increased, hypoaesthesia, malignant neoplasm progression, melaena. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, PREDONINE, KYTRIL, OXYCONTIN. Patient was hospitalized. Patient died on 06/01/2006.

Gemzar Side Effects Report #5055322-0
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2006. Female patient, 56 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, jaundice cholestatic, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, pancreatic carcinoma recurrent, pancreatic carcinoma stage iv, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #4872593-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 21, 2005. Female patient, 56 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: jaundice cholestatic, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, pancreatic carcinoma, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #4577884-X
Gemzar side effect was reported by a Physician from on Jan 20, 2005. Female patient, 54 years of age, weighting 72.75 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: decreased appetite, malignant neoplasm progression, pancreatic carcinoma stage iv, pleurisy, pyrexia. Gemzar dosage: 1000 MG. During the same period patient was treated with NEUROTROPIN, TOLEDOMIN, GRANDAXIN, DOGMATYL, HALCION, BERIZYM, BIOFERMIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4600206-2
Gemzar side effect was reported by a Physician from on Feb 10, 2005. Female patient, 54 years of age, weighting 72.75 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: decreased appetite, malignant neoplasm progression, pleurisy, pyrexia. Gemzar dosage: 1000 MG. During the same period patient was treated with NEUROTROPIN, TOLEDOMIN, GRANDAXIN, DOGMATYL, HALCION, BERIZYM, BIOFERMIN. Patient recovered.

Gemzar Side Effects Report #5452791-9
Gemzar side effect was reported by a Physician from JAPAN on Sept 11, 2007. Male patient, 45 years of age, weighting 139.8 lb, was diagnosed with pancreatic carcinoma stage iv, hepatic function abnormal, pyrexia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, fatigue, febrile neutropenia, malignant neoplasm progression, pancytopenia, pharyngolaryngeal pain, pruritus, pyrexia, rash

, prophylaxis, pancreatic enzymes, hyperchlorhydria, schizophrenia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cerebral infarction, fall

, hepatic function abnormal, malignant neoplasm progression, sepsis

, prophylaxis, pancreatic enzymes, hyperchlorhydria, schizophrenia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, hepatic function abnormal, malignant neoplasm progression, sepsis

. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with BIO THREE, FOIPAN, PANCREATIN TRIPLE STRENGTH CAP, GASMOTIN, TAKEPRON, ALOSENN, SERENACE, AKINETON. Patient died on 05/28/2008.

Gemzar Side Effects Report #5864440-6
Gemzar side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 139.8 lb, was diagnosed with pancreatic carcinoma stage iv, hepatic function abnormal, pyrexia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, fatigue, febrile neutropenia, malignant neoplasm progression, oropharyngeal pain, pancytopenia, pruritus, pyrexia, rash

. Gemzar dosage: 1776 MG, OTHER. During the same period patient was treated with CISPLATIN, URSOSAN, SULPERAZON, NOVAMIN, GRANISETRON, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/05/2003.

Gemzar Side Effects Report #5878941-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 28, 2008. Male patient, weighting 138.5 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis, hypertension, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemothorax, hiccups, malignant neoplasm progression, pyrexia. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with GASTER D, SEPAMIT, MYSLEE. Patient died on 09/06/2007.

Gemzar Side Effects Report #5891688-7
Gemzar side effect was reported by a Physician from JAPAN on May 07, 2008. Female patient, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction, malignant neoplasm progression, metastases to lymph nodes, metastases to stomach, thrombotic microangiopathy. Gemzar dosage: 1200 MG, OTHER. Patient was hospitalized and became disabled. Patient died on 07/24/2007.

Gemzar Side Effects Report #5891696-6
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5914923-5
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2008. Male patient, weighting 138.5 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis, hypertension, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemothorax, hiccups, malignant neoplasm progression, malignant pleural effusion. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with GASTER D, SEPAMIT, MYSLEE. Patient died on 09/06/2007.

Gemzar Side Effects Report #6045807-2
Gemzar side effect was reported by a Physician from JAPAN on May 07, 2008. Female patient, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction, malignant neoplasm progression, metastases to lymph nodes, metastases to stomach, thrombotic microangiopathy. Gemzar dosage: 1200 MG, OTHER. Patient was hospitalized and became disabled. Patient died on 07/24/2007.

Gemzar Side Effects Report #6077718-0
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5081628-5
Gemzar side effect was reported by a Physician from JAPAN on July 31, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to liver, pancytopenia. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. Patient was hospitalized. Patient died on 11/27/2004.

Gemzar Side Effects Report #5901332-8
Gemzar side effect was reported by a Physician from JAPAN on Sept 16, 2008. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma recurrent, type 1 diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, ascites, malignant neoplasm progression, metastases to lymph nodes, oedema, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient died on 09/30/2005.

Gemzar Side Effects Report #5943848-4
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma recurrent, type 1 diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, ascites, malignant neoplasm progression, metastases to lymph nodes, oedema, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient died on 09/30/2005.

Gemzar Side Effects Report #4765598-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 19, 2005. Female patient, 70 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma recurrent, pancreatic carcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ageusia, dysgeusia, malignant neoplasm progression, metastases to liver, nausea

, oral mucosal discolouration, stomatitis. Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with VOLTAREN, DUROTEP, PRIMPERAN, PROMAC, FOIPAN, EXCELASE, MAGMITT. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6115295-6
Gemzar side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, lung infiltration, malignant neoplasm progression, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, CREON, METOPROLOL TARTRATE, ZOCOR, METFORMIN, ZOFRAN, PROTONIX, COLACE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5943836-8
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 78 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 07/12/2005.

Gemzar Side Effects Report #5943859-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 12/07/2002.

Gemzar Side Effects Report #6033315-4
Gemzar side effect was reported by a Physician from JAPAN on Jan 07, 2009. Female patient, 74 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, intestinal obstruction, malignant neoplasm progression, performance status decreased, vomiting. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 10/16/2005.

Gemzar Side Effects Report #5943834-4
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 72 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 05/08/2002.

Gemzar Side Effects Report #5943844-7
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 11/07/2005.

Gemzar Side Effects Report #5886212-9
Gemzar side effect was reported by a Physician from JAPAN on Sept 04, 2008. Female patient, 65 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea

. Gemzar dosage: 1400 MG, OTHER. Patient died.

Gemzar Side Effects Report #5943835-6
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 56 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 05/17/2003.

Gemzar Side Effects Report #5774871-0
Gemzar side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, 52 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaphylactic shock, bone marrow failure, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Gemzar Side Effects Report #4985909-2
Gemzar side effect was reported by a Physician from FRANCE on Apr 06, 2006. Male patient, 74 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coma hepatic, insomnia, malignant neoplasm progression, peripheral sensory neuropathy. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CREON, PREVISCAN, MORPHINE SULPHATE. Patient died on 02/17/2006.

Gemzar Side Effects Report #4950039-2
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2006. Female patient, 58 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, ascites, malignant neoplasm progression, metastases to liver, pneumonia aspiration. Gemzar dosage: 1425 MG WEEKLY IV DRIP. During the same period patient was treated with TAXOTERE, XELODA. Patient died on 08/31/2005.

Gemzar Side Effects Report #4953713-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 23, 2006. Male patient, 34 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, cachexia, hyperkalaemia, hypoglycaemia, malignant neoplasm progression, mesenteric vein thrombosis, metastases to liver, metastases to lung, metastases to peritoneum. Gemzar dosage: 1280 MG WEEKLY IV DRIP. During the same period patient was treated with TAXOTERE, XELODA. Patient died on 03/21/2006.

Gemzar Side Effects Report #5509925-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2007. Male patient, weighting 172.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral ventricle dilatation, gastrointestinal haemorrhage, malignant neoplasm progression, mental status changes, metastases to gastrointestinal tract, pancreatic carcinoma. Gemzar dosage: 1000MG/M2 EVERY OTHER WEEK INTRAVENOUS DRIP. During the same period patient was treated with BEVACIZUMAB GENENTECH. Patient died on 11/02/2007.

Gemzar Side Effects Report #5509987-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2007. Male patient, weighting 172.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: duodenal ulcer, extravasation, gastrointestinal haemorrhage, malignant neoplasm progression, meningitis

, mental status changes, pancreatic carcinoma, tumour invasion. Gemzar dosage: 1000MG/M2 EVERY OTHER WEEK IV DRIP. During the same period patient was treated with BEVACIZUMAB GENENTECH. Patient died on 11/02/2007.

Gemzar Side Effects Report #5904566-1
Gemzar side effect was reported by a Physician from CANADA on Sept 22, 2008. Male patient was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pleural effusion, pulmonary embolism

, pulmonary toxicity, renal cyst. Gemzar dosage: 2030 MG, UNK. During the same period patient was treated with TARCEVA, ATACAND, ZOPICLONE, PREDNISONE, FLOVENT, VENTOLIN, HEPARIN. Patient died on 08/01/2008.

Gemzar Side Effects Report #5470645-9
Gemzar side effect was reported by a Physician from JAPAN on Sept 11, 2007. Male patient, 85 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea

, pleural effusion. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 06/01/2006.

Gemzar Side Effects Report #5337402-5
Gemzar side effect was reported by a Physician from UNITED STATES on June 27, 2006. Male patient, 80 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2. Patient died on 05/01/2006.

Gemzar Side Effects Report #5804646-5
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2008. Male patient, 80 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pulmonary embolism

. Gemzar dosage: 800 MG/M2, OTHER. Patient died on 01/01/2008.

Gemzar Side Effects Report #5823503-1
Gemzar side effect was reported by a Physician from JAPAN on July 18, 2008. Male patient, 80 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pulmonary embolism

. Gemzar dosage: 800 MG/M2, OTHER. Patient was hospitalized. Patient died on 06/22/2008.

Gemzar Side Effects Report #4546652-7
Gemzar side effect was reported by a Physician from on Dec 09, 2004. Female patient, 79 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, malignant neoplasm progression, metastases to lung, pancreatic carcinoma recurrent, shock haemorrhagic. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with DECADRON, NASEA, LOXONIN. Patient recovered.

Gemzar Side Effects Report #4579473-X
Gemzar side effect was reported by a Health Professional from on Jan 24, 2005. Female patient, 79 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, loss of consciousness, malignant neoplasm progression, metastases to lung. Gemzar dosage: 1000 MG. During the same period patient was treated with DECADRON, NASEA, LOXONIN. Patient recovered.

Gemzar Side Effects Report #4681908-9
Gemzar side effect was reported by a Physician from on May 12, 2005. Female patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypoaesthesia, malignant neoplasm progression, transient ischaemic attack. Gemzar dosage: unknown. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5241727-1
Gemzar side effect was reported by a Physician from GERMANY on Feb 09, 2007. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, prothrombin time prolonged, transaminases increased. Gemzar dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5521170-8
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice

, jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #6114939-2
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2008. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain

, ascites, back pain

, discomfort, malignant neoplasm progression, pancreatic neoplasm, pulmonary mass. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Gemzar Side Effects Report #5197098-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 21, 2006. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.

Gemzar Side Effects Report #5261054-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.

Gemzar Side Effects Report #4546604-7
Gemzar side effect was reported by a Physician from on Dec 14, 2004. Female patient, 73 years of age, weighting 85.98 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspiration, blood pressure systolic decreased, malignant neoplasm progression, paracentesis abdomen abnormal, pneumonia

, streptococcal infection

, urethral caruncle. Gemzar dosage: 1000 MG/M2/OTHER. During the same period patient was treated with LASIX, PURSENNID, SEROTONE. Patient died on 02/08/2003.

Gemzar Side Effects Report #4746417-7
Gemzar side effect was reported by a Consumer or non-health professional from JAPAN on July 29, 2005. Female patient, 73 years of age, weighting 85.98 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, asthenia, blood pressure systolic decreased, malignant neoplasm progression, pneumonia aspiration, urethral caruncle. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LASIX, SEROTONE, PICIBANIL. Patient died on 02/08/2003.

Gemzar Side Effects Report #4831325-3
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2005. Male patient, 73 years of age, weighting 184.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dyspnoea, malignant neoplasm progression, metastases to liver, oedema peripheral, oxygen saturation decreased, pancreatic carcinoma, pneumonia

, productive cough. Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4832377-7
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2005. Male patient, 73 years of age, weighting 184.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, dyspnoea, malignant neoplasm progression, metastases to liver, oedema peripheral, oxygen saturation decreased, pancreatic carcinoma, pneumonia

. Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992759-X
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 17, 2005. Male patient, 72 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea

, thrombocytopenia. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5239766-X
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 71 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, pain

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, bile duct stenosis, bone marrow failure, disseminated intravascular coagulation, interstitial lung disease, malaise, malignant neoplasm progression, nausea

, oedema. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with OMEPRAL, CAMOSTAT MESILATE, FUROSEMIDE, PENTAGIN, MAGMITT. Patient was hospitalized. Patient died on 10/29/2006.

Gemzar Side Effects Report #5774879-5
Gemzar side effect was reported by a Physician from FRANCE on June 05, 2008. Female patient, 71 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma, nausea

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, hepatic steatosis, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, septic shock. Gemzar dosage: unknown. During the same period patient was treated with ZOPHREN, PRIMPERAN. Patient was hospitalized. Patient died on 04/17/2008.

Gemzar Side Effects Report #4607544-8
Gemzar side effect was reported by a Physician from on Feb 24, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain

, blood pressure increased, condition aggravated, creatinine renal clearance decreased, haemolytic uraemic syndrome, iron deficiency anaemia, malignant neoplasm progression, marrow hyperplasia, oedema peripheral. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.

Gemzar Side Effects Report #4710757-8
Gemzar side effect was reported by a Physician from JAPAN on June 15, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain

, blood pressure increased, calcium ionised decreased, dialysis

, haemolytic uraemic syndrome, hypocalcaemia, iron deficiency anaemia, malignant neoplasm progression, marrow hyperplasia. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.

Gemzar Side Effects Report #5706557-2
Gemzar side effect was reported by a Physician from FRANCE on Apr 03, 2008. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma, steatorrhoea and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypoproteinaemia, malignant neoplasm progression, pancytopenia, proteinuria. Gemzar dosage: unknown. During the same period patient was treated with CREON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4546606-0
Gemzar side effect was reported by a Physician from on Dec 14, 2004. Female patient, 70 years of age, weighting 97.00 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, malignant neoplasm progression, metastases to lung, respiratory failure. Gemzar dosage: 200 MG OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5158680-1
Gemzar side effect was reported by a Physician from GERMANY on Nov 20, 2006. Female patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma, thrombocythaemia, thrombophlebitis migrans. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with ANTICOAGULANT CITRATE DEXTROSE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5579333-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, diabetes mellitus, malignant neoplasm progression, thrombocytopenia, white blood cell count decreased. Gemzar dosage: 1000 MG, WEEKLY(1/W). During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5338447-1
Gemzar side effect was reported by a Physician from JAPAN on May 23, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastric perforation, gastric ulcer, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 09/01/2006.

Gemzar Side Effects Report #4613259-2
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Male patient, 64 years of age, weighting 147.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice cholestatic, malignant neoplasm progression, oedema peripheral, pancreatic carcinoma, phlebothrombosis. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5013903-4
Gemzar side effect was reported by a Physician from UNITED KINGDOM on May 08, 2006. Female patient, 64 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cryptogenic organizing pneumonia, lethargy, malignant neoplasm progression, metastases to liver, pancreatic carcinoma, somnolence. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with OXYCONTIN, OXYNORM, ENOXAPARIN, PREGABALIN, VISCOTEARS, CARBOMER. Patient was hospitalized. Patient died on 04/13/2006.

Gemzar Side Effects Report #4546605-9
Gemzar side effect was reported by a Physician from on Dec 14, 2004. Female patient, 62 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hepatic failure, malignant neoplasm progression, metastases to liver, neutrophil count decreased, white blood cell count decreased. Gemzar dosage: 210 MG OTHER. During the same period patient was treated with VOLTARENE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4625890-9
Gemzar side effect was reported by a Physician from on Mar 14, 2005. Male patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, malignant neoplasm progression, pancreatic carcinoma, peritonitis bacterial, subileus. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with DEXAMETHASONE, KEVATRIL. Patient was hospitalized. Patient died on 02/01/2005.

Gemzar Side Effects Report #6069797-1
Gemzar side effect was reported by a Physician from JAPAN on Jan 29, 2009. Male patient, 61 years of age, weighting 119.0 lb, was diagnosed with pancreatic carcinoma, trousseau's syndrome and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, international normalised ratio fluctuation, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with HEPARIN, EDARAVONE, WARFARIN. Patient recovered.

Gemzar Side Effects Report #5129881-3
Gemzar side effect was reported by a Physician from FRANCE on Sept 26, 2006. Female patient, 59 years of age, weighting 172.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hepatic neoplasm malignant, malignant neoplasm progression, peripheral ischaemia. Gemzar dosage: 1920 MG, OTHER, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, KYTRIN. Patient died on 01/30/2006.

Gemzar Side Effects Report #5526551-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site infection, disease progression, hypersensitivity, malaise, malignant neoplasm progression, nausea

, weight decreased. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, TAXOTERE, PANCREATIC ENZYMES. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5170029-7
Gemzar side effect was reported by a Physician from JAPAN on Dec 01, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis, leukaemia, malignant neoplasm progression, white blood cell disorder. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5174403-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 01, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cholangitis, malignant neoplasm progression. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar and malignant neoplasm progression

SideEffects101.com

Gemzar and malignant neoplasm progression Patient Reports February 13, 2012

side effects of Gemzar